All In MedTech

FDA Clearance Tracker · P150011-S024

Perceval PLUS Sutureless Heart Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 7, 2022 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 7, 2022

Approved

Time to decision

179 days

Received Apr 11, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150011-S024
Device name
Perceval PLUS Sutureless Heart Valve
Applicant
Corcym S.r.l.
Applicant location
Saluggia
Received
Apr 11, 2022
Decided
Oct 7, 2022
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150011

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

approval for the Perceval RelyON PAK Accessories Kit for collapsing and releasing the Perceval PLUS valve and modification to the Instructions for Use to address the use of the new accessories.

Source documents

Other decisions for Corcym S.r.l.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.